Ruby L.Y. Chan
Impact in
- Microbiology top 2%
- Antimicrobial Peptides and Activities
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Traditional Chinese Medicine Analysis 3
-
- Bioactive Compounds and Antitumor Agents 2
- Co-authors
- Lin Zhang (7 shared papers)William Ka Kei Wu (7 shared papers)Jing Shen (6 shared papers)Tao Hu (5 shared papers)Mingxing Li (4 shared papers)Chi Hin Cho (4 shared papers)Lan Lu (3 shared papers)Kenneth K.W. To (2 shared papers)
- Journals
- Phytomedicine (3 papers)Cancer Research (2 papers)Life Sciences (2 papers)Current Pharmaceutical Design (1 paper)PLoS ONE (1 paper)
- Partner nations
- Hong KongChinaUnited States
In The Last Decade
Ruby L.Y. Chan
9 papers receiving 672 citations
Peers
Comparison fields: 5 of 57
- Microbiology 168
- Complementary and alternative medicine 86
- Cancer Research 100
- Oncology 117
- Molecular Biology 152
Countries citing papers authored by Ruby L.Y. Chan
This map shows the geographic impact of Ruby L.Y. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby L.Y. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby L.Y. Chan more than expected).
Fields of papers citing papers by Ruby L.Y. Chan
This network shows the impact of papers produced by Ruby L.Y. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby L.Y. Chan. The network helps show where Ruby L.Y. Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruby L.Y. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 131 | |
| 2 | 2012 | 120 | |
| 3 | 2014 | 111 | |
| 4 | 2014 | 89 | |
| 5 | 2015 | 79 | |
| 6 | 2015 | 64 | |
| 7 | 2016 | 41 | |
| 8 | 2013 | 39 | |
| 9 | 2012 | 5 |
About Ruby L.Y. Chan
Ruby L.Y. Chan is a scholar working on Complementary and alternative medicine, Toxicology, Microbiology, Cancer Research and Molecular Biology, having authored 9 papers that have together received 679 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (6 papers), Traditional Chinese Medicine Analysis (3 papers), Antimicrobial Peptides and Activities (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Autophagy in Disease and Therapy (2 papers), MicroRNA in disease regulation (2 papers), Mitochondrial Function and Pathology (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Microbiology (168 citations), Complementary and alternative medicine (86 citations), Cancer Research (100 citations), Oncology (117 citations) and Molecular Biology (152 citations). Ruby L.Y. Chan has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Lin Zhang, William Ka Kei Wu, Jing Shen, Tao Hu, Mingxing Li, Chi Hin Cho, Lan Lu, Kenneth K.W. To, Simon S.M. Ng and Shun Xiang Ren. Their work appears in journals such as Phytomedicine, Cancer Research, Life Sciences, Current Pharmaceutical Design and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.